Kailash Ukhade joined Jubilant Ingrevia as Vice President - Projects

Published On 2025-07-14 10:54 GMT   |   Update On 2025-07-14 10:54 GMT
Advertisement

Noida: Jubilant Ingrevia has named Kailash Ukhade as new Vice President - Projects based in Bharuch.

In a LinkedIn post, the company stated, "We’re pleased to welcome Kailash Ukhade as Vice President – Projects based in Bharuch."
Kailash brings over 30 years of rich experience in leading large-scale greenfield and brownfield projects across the API, Intermediates, and Chemical sectors. His expertise spans the entire project lifecycle—from design and capex procurement to construction, safety, and delivery.
In his new role, he will lead the Projects function with a focus on execution excellence, safety, cost control, and process standardization, collaborating closely with the Design, Technical, Operations, and PMO teams.

Before joining Jubilant Ingrevia, Ukhade held senior positions at Farmson Basic Drugs Pvt. Ltd., Biopharmax India, Pharmsol Group, Dubai, UAE

He has also worked with several pharmaceutical companies, including Dr. Reddy’s Laboratories, Cadila Pharmaceuticals, Lupin, GlaxoSmithKline, PHLOX Pharmaceuticals Ltd ( Now accquired by SUN Pharma ), Sun Pharma, Apicore Pharmaceuticals (India) Pvt. Ltd., Vadodara.

In addition to pharma, he has held roles at Larsen & Toubro – Technology Services,Oman Chemicals & Pharmaceuticals LLC, Sultanate of Oman, United Phosphorus etc.

Read also: Jubilant Biosys appoints Venugopala Reddy Pagadala as VP & CFO, CRDMO

Jubilant Ingrevia is a global integrated Life Science products and Innovative Solutions provider serving, Pharmaceutical, Nutrition, Agrochemical, Consumer and Industrial customers.

The company offers a broad portfolio of ingredients that find application in a wide range of industries. Jubilant Ingrevia’s portfolio also extends to custom development and manufacturing for pharmaceutical and agrochemical customers on an exclusive basis.

Read also: Jubilant Radiopharma business receives ANDA approval for Technetium Sulfur Colloid Injection

Tags:    

Disclaimer: This website is primarily for healthcare professionals. The content here does not replace medical advice and should not be used as medical, diagnostic, endorsement, treatment, or prescription advice. Medical science evolves rapidly, and we strive to keep our information current. If you find any discrepancies, please contact us at corrections@medicaldialogues.in. Read our Correction Policy here. Nothing here should be used as a substitute for medical advice, diagnosis, or treatment. We do not endorse any healthcare advice that contradicts a physician's guidance. Use of this site is subject to our Terms of Use, Privacy Policy, and Advertisement Policy. For more details, read our Full Disclaimer here.

NOTE: Join us in combating medical misinformation. If you encounter a questionable health, medical, or medical education claim, email us at factcheck@medicaldialogues.in for evaluation.

Our comments section is governed by our Comments Policy . By posting comments at Medical Dialogues you automatically agree with our Comments Policy , Terms And Conditions and Privacy Policy .

Similar News